Award Data

The applicant will develop a wave energy harvesting system for NOAA buoys. It will ve entirely self-contained (no protruding elements), modular, scalable, and easily deployed. The system employs a unique, inertial mechanism that responds to acceleration forces created by waves. This mechanism will be combined with (1) a proprietary generator that is sensitive to very low levels of torque and ha ...

Toyon proposes to develop software that can process infrared video streams to automatically detect gray whale blows. Additionally, the software will count the number of blows and estimate the speed and the number of whales that are present. We will make use of a novel technique for whale blow detection that Toyon has demonstrated on infrared video of humpback whales. The approach makes use of b ...

The gray whale migration generates many hours of video that must be examined carefully to identify passing whales and get an accurate count of their numbers. Unfortunately, humans lack the necessary attention span. To solve this problem, a detector will be developed that can process hours of video, detecting whale blows while minimizing false positives and negatives. With an accurate record of ...

DESCRIPTION (provided by applicant): Point of care testing is a test that is performed near or at the site of care. In addition it has come to imply a rapid turnaround time, ease of use and convenience for the patient. Traditional Point of Care single usecartridge tests are lateral flow immunoassay tests where the capture antibody is labeled with a chromagen, which allows for a positive reaction t ...

DESCRIPTION (provided by applicant): Trellis Bioscience has developed its patented CellSpot technology into a robust platform for characterizing the secreted antibody from single human lymphocytes with regard to specificity and affinity against multiple antigens. For example, the platform was used to isolate a rare, high quality human antibody to Respiratory Syncytial Virus (RSV) that is now bein ...

DESCRIPTION (provided by applicant): Trellis Bioscience has developed its patented CellSpot technology into a robust platform for characterizing the secreted antibody from single human lymphocytes with regard to specificity and affinity against multiple antigens. For example, the platform was used to isolate a rare, high quality human antibody to Respiratory Syncytial Virus (RSV) that is now bein ...

DESCRIPTION (provided by applicant): The influenza A virus represents one of the greatest global human health risks. Although vaccines provide significant protection from seasonal flu infections they still account for an estimated 36,000 deaths and 200,000hospitalizations per year in the US alone. Furthermore, the inherent time involved in development, production and distribution of vaccines limit ...

DESCRIPTION (provided by applicant): There is an urgent need to discover more effective therapeutic regimens for fungal infections. Nosocomial infections caused by Candida albicans have a 50% mortality rate. Aspergillosis is a leading cause of death in organ transplant recipients, as well as patients suffering from cancer and auto-immune disorders. The annual cost of treating fungal infections is ...

DESCRIPTION (provided by applicant): Despite the rise of bacterial resistance to antibiotics, the development of new antibiotics is on the decline. Methicillin-resistant Staphococcal aureus infections (MRSA) in the United States has been increasing, causing 19,000 deaths per year in the United States and contributing to 3 billion to 4 billion of additional annual health care costs. The issue of ...

DESCRIPTION (provided by applicant): The primary objective of this project is to build on prior Phase 1 research to improve product sensitivity properties, to refine and test modifications of the Origami Male Condom 1 (OMC 1), and develop a more consumer-acceptable device exclusively for vaginal-penile intercourse, the Origami Male Condom 3 (OMC 3). Made of custom formulated biocompatible, viral-i ...